Big Chemical Encyclopedia

Chemical substances, components, reactions, process design ...

Articles Figures Tables About

Detection metabolite

When fish of both populations were exposed to 80 yg/1 14c-aldrin, dieldrin was the only detectable metabolite in the organic extracts of the liver. The percentage of radioactivity in the water-soluble fraction in both populations was small. Although previous work had indicated a greater production of water-soluble metabolite(s) in the R population (15), more recent work indicated that the relative proportion of racTToactivity in the water-soluble fraction was similar in both populations (Table VII). [Pg.152]

The anticonvulsant agent primidone (4.246) is the 2-dihydro derivative of phenobarbital (4.247), which is one of its metabolites. The second major metabolite, 2-ethyl-2-phenylmalondiamide (4.248), is produced by a double C-N cleavage [160]. The profile of plasma levels in rats strongly suggests that 2-ethyl-2-phenylmalondiamide is not derived from the metabolite phenobarbital, but directly from primidone. Indeed, a C(2)-hydroxylated metabolite serves as an intermediate for both detected metabolites (see also Chapt. 6 in [21]). N-Alkyl derivatives of primidone yield a greater proportion of ring-opened metabolites, an observation explained by their higher susceptibility to oxidative metabolism at C(2) [161]. [Pg.161]

The metabolites of [3H] /ra ,v-resveratrol detected in tissues and plasma were also investigated. In kidney, liver, heart, lungs, brain, and plasma (2-h samples), the only metabolite found was resveratrol glucuronide. Glucuronides in plasma and kidney disappeared completely at 18 h. In lungs, liver, heart, and brain, the main detected metabolite at 18 h was the /ra ,v-resveratrol (Table 13.2). This study provided data on the metabolic fate of resveratrol. While glucuronides were predominant in plasma and tissues at the earlier times, the aglycone represented the main form at later times [El-Mohsen et al., 2006]. [Pg.278]

Figure 5.9. LC-MS (TIC) and UV (220 nm) chromatograms for microsomal incubation of verapamil containing parent molecule and detected metabolites. Data-dependent accurate mass measurements for verapamil, metabolite parents and fragment ions are shown in the inset. Figure 5.9. LC-MS (TIC) and UV (220 nm) chromatograms for microsomal incubation of verapamil containing parent molecule and detected metabolites. Data-dependent accurate mass measurements for verapamil, metabolite parents and fragment ions are shown in the inset.
In vitro reductive metabolism of 14C-nitrobenzene was significantly greater in the cecal contents of rats fed NIH-07 than that in the cecal contents of either of the groups fed the AIN-76A-based diets (Table V). Furthermore, nitrobenzene metabolism by cecal contents tended to be greatest in animals fed NIH-07, least in animals fed AIN-76A, and intermediate in those fed AIN-76A containing pectin. Metabolites of nitrobenzene produced by cecal contents of animals fed NIH-07 and AIN-76A containing pectin included aniline, nitrosobenzene, and azoxybenzene, whereas aniline was the only detectable metabolite observed in animals fed the AIN-76 A diet (Table V). [Pg.53]

A study reported the mechanism of the turnover of a 2-thiopenem by a class A /3-lactamase <1993JA4962> the resulting detected metabolite is a ketene dithioacetal 40 as shown in Scheme 22. [Pg.199]

Preincubation of human liver microsomes (HLMs) with cannabidiol decreased the formation of all detectable metabolites of cyclosporine, a substrate of CYP3A (9). Cannabidiol is metabolized by CYP3A to form a cannabidiol hydroxyquinone. This metabolite binds to the apoprotein of CYP3A and renders it inactive (10). [Pg.517]

It should be noted that the mechanism depicted in Scheme 1 is the simplest that is consistent with mechanism-based inhibition. The mechanism for a given inhibitor and enzyme may be considerably more complex due to (a) multiple intermediates [e.g., MIC formation often involves four or more intermediates (29)], (b) detectable metabolite that may be produced from more than one intermediate, and (c) the fact that enzyme-inhibitor complex may produce a metabolite that is mechanistically unrelated to the inactivation pathway. Events such as these will necessitate alternate definitions for Z inact, Kh and r in terms of the microrate constants of the appropriate model. The hyperbolic relationship between rate of inactivation and inhibitor concentration will, however, remain, unless nonhyperbolic kinetics characterize this interaction. Silverman discussed this possibility from the perspective of an allosteric interaction between inhibitor and enzyme (5). Nonhyperbolic kinetics has been observed for the interaction of several drugs with members of the CYPs (30). [Pg.521]

Figure 4.5 The initial convergence regions (panels (i), (iv)), absorption total shape spectra (panels (ii), (v)), and absorption component shape spectra (panels (iii), (vi)) in the FPT+) (left column) and FPT-) (right column). The middle panels display the usual abbreviations for the main MR-detectable metabolites in the healthy human brain, whereas the bottom panels give the corresponding numbers of these metabolites (see Table 4.1). Figure 4.5 The initial convergence regions (panels (i), (iv)), absorption total shape spectra (panels (ii), (v)), and absorption component shape spectra (panels (iii), (vi)) in the FPT+) (left column) and FPT-) (right column). The middle panels display the usual abbreviations for the main MR-detectable metabolites in the healthy human brain, whereas the bottom panels give the corresponding numbers of these metabolites (see Table 4.1).
How many peaks in a cluster Can we detect small impurities Can we detect metabolites against a background Can we determine whedier there are embedded peaks ... [Pg.340]

Van der Greel J, Leegwater DC. 1983. Urine profile analysis by field desorbtion mass spectrometry, a technique for detecting metabolites of xenobiotics. Biomed Mass Spec 10(1 ) 1-4. [Pg.156]

The authors also combined metabolomics results with results obtained from AFP determinations. The model was created using linear discriminant analysis. Principal component analysis was also carried out. Thanks to the created model, it was possible to detect metabolites of potential diagnostic value. Moreover, analysis of metabolomic profiles decreased the number of patients that were incorrectly classified with the use of AFP marker [21]. [Pg.251]

FIGURE 69.2. Reaction scheme of acetylcholinesterase inhibition, reactivation, and protection activities. OPH, 2-PAM, and paraoxon are used in the example. Reaction (I) - cholinesterase AChE reaction with ASCh Reaction (II) - inhibition of AChE inhibition by paraoxon Reaction (III) - aging of AChE associated with OP exposure Reaction (TV) -reactivation of AChE by 2-PAM Reaction (V) - hydrolysis of paraoxon by OPH Reaction (VI) - reaction of 2-PAM oxime with ASCh and Reaction (VII) - DTNB reaction with SCh. The indicates a photometrically detectable metabolite. [Pg.1046]

Biomarkers of Exposure and Effect. For high exposure to 1,1 -dichloroethane, the levels of this compound in the blood, urine, and breath may be used for biomarkers of exposure. However, these methods should be more sensitive and quantitative. The development of methods for detecting metabolites in the fluids and tissue of humans is needed to indicate 1,1-dichloroethane exposure. [Pg.49]

Indicators to detect metabolites are of great interest, but reliable systems are not yet commercially available. [Pg.376]

Orbitrap or Q-ToF generations can be used for both. Integrating proteomics can help to overcome the major gap between gene expression and observed phenotype because altered expression of an enzyme may not change metabolite pools, but additional posttranslational modification does. Furthermore, from the metabolomics side increased metabolome coverage can improve combined data analysis. Currently, no methods that can cover all metabolites are available, but a combination of different analytical approaches (e.g., RP and HILIC separation) can improve the detected metabolite space. [Pg.441]

An assay for ethanol in blood plasma has been published and a comprehensive listing of the H NMR-detectable metabolites observed in the various ID and 2D experiments, together with their spin systems and their H chemical shifts (and shifts where available) in plasma, is given in Table 2. [Pg.28]


See other pages where Detection metabolite is mentioned: [Pg.334]    [Pg.163]    [Pg.167]    [Pg.710]    [Pg.104]    [Pg.367]    [Pg.117]    [Pg.155]    [Pg.291]    [Pg.142]    [Pg.147]    [Pg.209]    [Pg.211]    [Pg.242]    [Pg.285]    [Pg.292]    [Pg.260]    [Pg.406]    [Pg.272]    [Pg.319]    [Pg.404]    [Pg.241]    [Pg.62]    [Pg.373]    [Pg.931]    [Pg.756]    [Pg.756]    [Pg.323]    [Pg.188]    [Pg.244]    [Pg.180]    [Pg.3]    [Pg.76]    [Pg.140]   
See also in sourсe #XX -- [ Pg.89 ]




SEARCH



© 2024 chempedia.info